|
FY2025
12 months to Sep 27, 2025
|
FY2024
12 months to Sep 28, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Oct 1, 2022
|
FY2021
12 months to Oct 2, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net Income | |||||
| Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity | |||||
| Depreciation | |||||
| Amortization | |||||
| Deferred income taxes | |||||
| Gain (Loss) on Disposition of Business | |||||
| Gain on Sale of Property, Plant, and Equipment | |||||
| Goodwill, Impairment Loss | |||||
| Effect of Exchange Rate on Cash | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | |||||
| Restricted Cash | |||||
| Cash and cash equivalents | |||||
| Other Asset Impairment Charges | |||||
| Stock-based compensation expense | |||||
| Other, net | |||||
| Increase (Decrease) in Accounts Receivable | |||||
| Increase (Decrease) in Inventories | |||||
| Increase (Decrease) in Accounts Payable | |||||
| Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | |||||
| Increase (Decrease) in Interest Payable, Net | |||||
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | |||||
| Cash Provided by Operating Activities | |||||
| Cash Flows From Investing Activities: | |||||
| Additions to property, plant and equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from Sale of Property, Plant, and Equipment | |||||
| Proceeds from sale of businesses | |||||
| Payments to Acquire Equity Method Investments | |||||
| Other, net | |||||
| Cash Used for Investing Activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from issuance of debt | |||||
| Repayments on debt | |||||
| Proceeds from Issuance of Commercial Paper | |||||
| Repayments of Commercial Paper | |||||
| Purchases of Tyson Class A common stock | |||||
| Effective Income Tax Rate Reconciliation, Net Unrecognized Tax Benefits, Percent | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance | |||||
| Dividends | |||||
| Stock options exercised | |||||
| Other, net | |||||
| Cash Used for Financing Activities | |||||
Loading...
